iNGENu CRO
Bio
iNGENū CRO, led by Dr. Sud Agarwal, is an Australian-based contract research organization (CRO) focusing on providing cost-effective, FDA-compliant clinical trials.
Stories (4)
Filter by community
Rethinking Breast Cancer Trials: A Clinical Perspective from Dr. Sud Agarwal, CEO of iNGENū CRO
At 38, Rachel had weathered a double mastectomy, chemotherapy, and years of hormone therapy. Her scans were clear. Her doctors were pleased. But Rachel still struggled with lingering fatigue, joint pain, and a sense that her treatment story was being measured by numbers that didn't fully reflect her reality.
By iNGENu CRO5 months ago in FYI
Neuropathic Pain: A Roadmap to Better Treatments - Insights from Dr. Sud Agarwal and iNGENŪ CRO
Neuropathic pain, a complex and often debilitating condition, presents a significant challenge to both patients and healthcare providers. The International Classification of Diseases (ICD-11) defines pain as arising from damage or disease affecting the somatosensory nervous system, manifesting as sensory disturbances like electric, burning, or shock-like sensations. Unlike nociceptive pain resulting from tissue injury, this type of pain stems from malfunctioning in the nervous system itself.
By iNGENu CRO9 months ago in FYI
Navigating Financial Headwinds with iNGENū CRO: Challenges and Strategies for Biotech Companies in 2025
Early and mid-stage biotech companies in 2025 face a significantly challenging financial landscape compared to the boom years of the early 2020s. The sector has transitioned from exuberant investment to a "funding winter," grappling with constrained capital due to an IPO drought, weak stock markets, uncertain government R&D funding, cautious venture capital, and escalating R&D costs. This article explores these key financial challenges and strategic solutions, with a focus on how iNGENu CRO supports biotech companies in optimizing budgets and accelerating timelines.
By iNGENu CRO10 months ago in FYI
Pioneering FDA-Compliant Decentralized Trials In Asia-Pacific: iNGENū CRO Leads The Way
While DCTs are gaining significant traction in the USA and parts of the EU, no Contract Research Organization (CRO) has successfully scaled decentralized clinical trials across the Asia-Pacific region—until now.
By iNGENu CRO12 months ago in FYI
